Company: JACS-RI
Filing Date: 2025-01-15
Form Type: 10-Q
Source: 0001213900-25-003881
Chunk: 14

Company: Jackson Acquisition Co II
Filing Date: 2025-01-15
Form: 10-Q
Item: Part I, Item 1
Chunk 14
---
000,000 Units, which includes the full exercise by the underwriters of their over-allotment option in the
amount of 3,000,000 Units, at a price of $10.00 per Unit. Each Unit consists of one Class A ordinary share and one right entitling the
holder thereof to receive one tenth (1/10) of one Class A ordinary share upon the consummation of an initial Business Combination, as
described in more detail below (the “Public Share Rights”). Each ten Public Share Rights entitle the holder thereof to receive
one Class A ordinary share at the closing of an initial Business Combination. The Company will not issue fractional Class A ordinary shares.

NOTE 4. PRIVATE PLACEMENT

Simultaneously with the closing of the Initial
Public Offering, the Sponsor and Roth purchased an aggregate of 840,000 Private Placement Units (495,000 Private Placement Units purchased
by the Sponsor and 345,000 Private Placement Units purchased by Roth or its designees), at a price of $10.00 per Private Placement Unit
from the Company in a private placement, generating gross proceeds of $8,400,000. A portion of the proceeds from the sale of the Private
Placement Units was added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete
a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Units held in the Trust Account
will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law). The Private Placement Units
(including the underlying ordinary shares (“Private Placement Shares”) and rights (“Private Placement Rights”))
are identical to the Public Units (including the underlying Public Shares and Public Share Rights) sold in the Initial Public Offering.

NOTE 5. RELATED PARTY TRANSACTIONS

Founder Shares

 On September 13, 2024, the Sponsor paid $25,000
to cover certain offering and formation costs of the Company in consideration for 5,750,000 Class B ordinary shares (the “Founder
Shares”) issued to the Sponsor. Up to 750,000 of the Founder Shares were to be surrendered by the Sponsor for no consideration depending
on the extent to which the underwriters’ over-allotment was exercised. On December 11, 2024, the underwriters exercised their over-allotment
option in full as part of the closing of the Initial Public Offering. As such, the